| Josh Cochran 11919, Pllc | |
|
11919 W Sunset Highway Airway Heights WA 99001 | |
| (509) 903-8719 | |
| Not Available |
| Full Name | Josh Cochran 11919, Pllc |
|---|---|
| Speciality | Dentist |
| Location | 11919 W Sunset Highway, Airway Heights, Washington |
| Authorized Official Name and Position | Joshua Cochran (OWNER) |
| Authorized Official Contact | 5094751362 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Josh Cochran 11919, Pllc 13514 E 32nd Ave Spokane Valley WA 99216-6002 Ph: (206) 755-6436 | Josh Cochran 11919, Pllc 11919 W Sunset Highway Airway Heights WA 99001 Ph: (509) 903-8719 |
| NPI Number | 1396496113 |
|---|---|
| Provider Enumeration Date | 01/13/2022 |
| Last Update Date | 04/28/2022 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396496113 | NPI | - | NPPES |
| DE60295294 | Other | WA | STATE OF WA |
| DE60606819 | Other | WA | STATE OF WA |
| DE60593835 | Other | WA | STATE OF WA |
News Archive
For years, women have been told that weight gain could lead to heart disease. A new study indicates that it is the location of the fat that matters most, with abdominal fat representing the greatest harm and not overall body mass index when assessing risk for coronary artery disease.
Stand Up To Cancer (SU2C) and the Dutch Cancer Society (KWF Kankerbestrijding), along with the American Association for Cancer Research (AACR), SU2C's Scientific Partner, announce the recipients of the Sta Op Tegen Kanker International Translational Cancer Research Grant.
A collaboration of researchers, led by Dr. Martine Roussel of St. Jude Children's Research Hospital, has developed a novel mouse model of medulloblastoma - the most prevalent malignant pediatric brain tumor - that the researchers hope will more accurately represent the genetic changes involved in human brain tumor development.
Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited (Takeda) today announced the signing earlier this year of an agreement in which Teva licensed to Takeda the right to commercialize Teva's innovative glatiramer acetate ( active ingredient) formulation for the treatment of multiple sclerosis, in Japan.
Results presented today at The International Liver Congress 2015 demonstrate that hepatitis C (HCV)-infected genotype-3 (GT-3) patients, with and without cirrhosis, receiving 24 weeks of sofosbuvir (SOF) in combination with ribavirin (RBV) and peginterferon (PEG) achieved the highest sustained virologic response rates at 12 weeks (SVR12), observed in a Phase 3 study, to date.
› Verified 9 days ago
Airway Heights Dental Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: W. 13326 14th Street, Airway Heights, WA 99001 Phone: 509-244-3655 Fax: 509-244-9527 |